U.S. flag

An official website of the United States government

Filters

reset all
See more specimen types...

Other countries

See more countries

Results: 1 to 20 of 32

Tests names and labsConditionsGenes, analytes, and microbesMethods

Spinocerebellar Ataxia Panel

Mayo Clinic Laboratories Mayo Clinic
United States
55
  • T Targeted variant analysis

SCA Panel (SCA1, 2, 3, 6, 7) test

Neurogenetics Department Cyprus Institute of Neurology and Genetics
Cyprus
55
  • T Targeted variant analysis

Ataxin 3 (ATXN3) gene CAG triplet repeat test

Neurogenetics Department Cyprus Institute of Neurology and Genetics
Cyprus
11
  • T Targeted variant analysis

ATXN3 - Repeat expansion analysis

Centogene AG - the Rare Disease Company
Germany
11
  • T Targeted variant analysis

Ataxia / Spastic Paraplegia Comprehensive Panel

Centogene AG - the Rare Disease Company
Germany
451452
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Ataxia Repeat Expansion Panel

Centogene AG - the Rare Disease Company
Germany
1313
  • T Targeted variant analysis

Machado-Joseph Disease (MJD)/Spinocerebellar Ataxia Type 3 (SCA3) via the ATXN3 CAG Repeat Expansion

PreventionGenetics, part of Exact Sciences
United States
11
  • T Targeted variant analysis

Spinocerebellar ataxia type 3 presymptomatic testing

Genetics Service Unit National Institute of Biomedical Genomics
India
11
  • T Targeted variant analysis

Spinocerebellar ataxia type 3

Genetics Service Unit National Institute of Biomedical Genomics
India
11
  • T Targeted variant analysis

Spinocerebellar ataxia type 3

Molecular Diagnostic Laboratory Diagnostic Services, Shared Health Manitoba
Canada
11
  • T Targeted variant analysis

Spinocerebellar Ataxia type 3, Machado Joseph disease (SCA3, CAG expansion on ATXN3 gene)

CGC Genetics Unilabs
Portugal
11
  • T Targeted variant analysis

Spinocerebellar Ataxia (SCA) Type 3

Duzen Laboratories Duzen BBAGUAS
Turkey
11
  • T Targeted variant analysis

Spinocerebellar Ataxia Type 3 Repeat Analysis

GeneDx
United States
11
  • T Targeted variant analysis

Spinocerebellar Ataxia Repeat Expansion Analysis

GeneDx
United States
66
  • T Targeted variant analysis

Comprehensive Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36, DRPLA & FRDA)

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
1212
  • T Targeted variant analysis

ATXN3 (Spinocerebellar Ataxia Type 3) Repeat Expansion

Fulgent Genetics
United States
11
  • T Targeted variant analysis

Ataxia Repeat Expansion Analysis

Fulgent Genetics
United States
1915
  • T Targeted variant analysis

Spinocerebellar ataxia type 3

Molecular Genetics Laboratory North York General Hospital
Canada
11
  • T Targeted variant analysis

Comprehensive Spinocerebellar Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36 & DRPLA)

MNG Laboratories (Medical Neurogenetics, LLC.)
United States
1111
  • T Targeted variant analysis

SPINOCEREBELLAR ATAXIA (AUTOSOMAL DOMINANT) (SCAs)

Laboratorio de Genetica Clinica SL
Spain
1819
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

Results: 1 to 20 of 32

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.